3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Survival: new trials by email Literature Review of Survival trials Research Report on Survival
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation Sirolimus/tacrolimus, cyclosporine/methotrexate - Graft-versus-host Disease, Survival | Phase 3 | Completed | Karolinska Institutet | 215 | 2007-09-01 | 2015-04-14 |
| Application of ATP Infusions in Palliative Home Care Adenosine 5'-triphosphate - Cancer, Palliative Care | Phase 3 | Completed | Maastricht University Medical Center | 100 | 2002-03-01 | 2016-10-25 |
| Fluid Resuscitation With HES 200/0.5 10% in Severe Burn Injury fluid resuscitation, Fluid resuscitation - Survival, Renal Failure | Phase 3 | Completed | University of Zurich | 28 | 1997-04-01 | 2010-05-11 |
Graft vs Host Disease (1) · Neoplasms (1) · Renal Insufficiency (1)
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Immune System Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Adenosine Triphosphate (1) · Cyclosporine (1) · Methotrexate (1) · Sirolimus (1) · Tacrolimus (1)
Karolinska Institutet (1) · Maastricht University Medical Center (1) · University of Zurich (1)
Netherlands (1) · Sweden (1) · Switzerland (1)
Olle Ringden, M.D. Ph.D. (1) · P.C. Dagnelie, PhD (1)